Cure My Disease

Don't miss your cure!

 Log in / Sign up

Zapping the brain while in VR: a new hope for social skills?

NCT ID NCT07500103

Symptom relief Sponsor: I.R.C.C.S. Fondazione Santa Lucia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to help people with cerebellar diseases (either present from birth or developed later) improve their ability to predict others' actions and emotions. Sixty participants will undergo eight sessions of virtual reality training while receiving either real or fake (sham) brain stimulation. The goal is to see if this combination can boost social cognition and daily interactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for patients with cerebellar malformation include: * Documented malformations confined to the cerebellum confirmed by a 3T brain MRI scan; * Age ranging from 12 to 32 years old; * IQ \>= 50; * Absence of extra-cerebellar malformations on conventional brain MRI scan. Inclusion Criteria for patients with degenerative cerebellar atrophy include: * Evidence of diffuse cerebellar atrophy; * More than 6 months of illness; * IQ \>=75; * Absence of any cortical lesion on conventional brain MRI scans Exclusion Criteria for both groups include: * Presence of severe motor and visual impairments, as well as neurodevelopmental (i.e., autism), neurological or psychiatric disorders that could interfere with task execution and protocol compliance; * Presence of any contraindication for tACS.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebellar degeneration are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebellar degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebellar degeneration Cerebellar malformation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • I.R.C.C.S. Fondazione Santa Lucia

    NOT_YET_RECRUITING

    Roma, 00179, Italy

  • IRCCS National Neurological Institute "C. Mondino" Foundation

    RECRUITING

    Pavia, 27100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.